Sinopharm, CoronaVac to be assessed for emergency use: WHO
(VOVWORLD) - Chinese vaccines Sinopharm and CoronaVac (Sinovac) are on the final stage of evaluation by the Emergency Use Listing of the World Health Organization and a final decision should be made between April 26 and May 3, a WHO official said in a press conference on Friday.
 Chinese vaccine Sinopharm (Photo: Yicai Global/ VNA) |
Rogerio Pinto de Sa Gaspar, director of regulation and prequalification said the WHO has convened the technical advisory group for a vaccine assessment for the 26th of April, adding that "at least one of the two" could be evaluated on that date.
He said if one of those cannot make it for the 26th of April, the organization is planning also to have another technical advisory group on the week of May 3rd.
The Emergency Use Listing, WHO's internal procedure to assess unlicensed vaccines, is necessary for vaccines to be used under the COVAX Facility, a WHO-led initiative aimed at providing more equitable access to vaccines for low and middle-income countries.